John D Diekman's Net Worth

$179 Million

Who is John D Diekman?

John D Diekman has an estimated net worth of $179 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Zai Lab Ltd, Crinetics Pharmaceuticals, Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., ARVINAS, INC., Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., EPIRUS Biopharmaceuticals, Inc., and AFFYMETRIX INC.

SEC CIK

John D Diekman's CIK is 0001240357

Past Insider Trading and Trends

2019 was John D Diekman's most active year for acquiring shares with 26 total transactions. John D Diekman's most active month to acquire stocks was the month of January. 2022 was John D Diekman's most active year for disposing of shares, totalling 46 transactions. John D Diekman's most active month to dispose stocks was the month of October. 2024 saw John D Diekman paying a total of $12,026,030.94 for 5,206,074 shares, this is the most they've acquired in one year. In 2019 John D Diekman cashed out on 8,470,662 shares for a total of $54,804,484.83, their largest year based on trade value.